SAT Hospital in Keralam rejects charges of ‘clinical trial drugs’ given to SMA-afflicted children
Hospital Superintendent says decision to provide SMA patients with a less expensive, generic version of the original molecule against SMA, in place of the imported original drug costing several lakhs of rupees for a single vial, was taken by a technical committee comprising experts in the field
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.thehindu.com — the content belongs to The Hindu - National.
